PTGX compared with TNGX: revenue, margins and what each company keeps, and the suppliers and customers both name

PTGXProtagonist Therapeutics, Inc

Mkt capRevenueRevenue

TNGXTango Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

PTGXProtagonist Therapeutics, Inc

TNGXTango Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only PTGX 2

JNJJanssen Biotech, Inc., a Johnson & Johnson company ("JNJ")customer

TAKTakeda Pharmaceuticals, Inc. ("Takeda")customer

Shared 0

No shared counterparties.

Only TNGX 1

—WuXi AppTecunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

PTGXProtagonist Therapeutics, Inc

132.31▼−2.18%· post 132.31

Mkt cap$8.6BRevenue$274MQ3 FY26Revenue$46MFY25

TNGXTango Therapeutics, Inc.

21.49▲+2.96%· post 21.49

ClosedNov 6 '26

Mkt cap$3.6BRevenue$54MQ3 FY25Revenue$42MFY24

Compare

ClosedNov 6 '26

PTGXProtagonist Therapeutics, Inc

TNGXTango Therapeutics, Inc.

132.31▼−2.18%post 132.31

Price

21.49▲+2.96%post 21.49

$8.6B

Mkt cap

$3.6B

Q3 FY26$274M

Revenue

$54MQ3 FY25

FY25$46M

Revenue

$42MFY24

PTGX132.31▼−2.18%vsTNGX21.49▲+2.96%ClosedNov 6 '26